143 / 172
143
arthritis. A randomized controlled trial. Patient Educ
Couns;82:42-8.
13. Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A,
Harris G, et al. Cyclooxygenase-2 selective non-steroidal anti-
inflammatory drugs (etodolac, meloxicam, celecoxib,
rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for
osteoarthritis and rheumatoid arthritis: a systematic review
and economic evaluation. Health Technol Assess 2008;12:1-
278.
14. van Everdingen AA, Jacobs JW, Siewertsz Van Reesema
DR, Bijlsma JW. Low – dose prednisone therapy for patients
with early rheumatoid
arthritis:clinicalefficacy, disease-
modifying properties,and side effects:a randomized,double-
blind, placebo-controlled clinical trial. Ann Intern Med
2002;136:1-12.
15. O'Dell JR, Haire CE, Erikson N, Drymalski W, Palmer W,
Eckhoff PJ, et al. Treatment of rheumatoidarthritis with
methotrexate alone, sulfasalazine and hydroxychloroquine, or
a combination of all three medications. N Engl J Med
1996;334:1287-91.
16. Williams HJ, Ward JR, Dahl SL, Clegg DO, Willkens RF,
Oglesby T, et al. A controlled trial comparing sulfasalazine,
gold sodium thiomalate, and placebo in rheumatoid arthritis.
Arthritis Rheum 1988;31:702-13.
17. Boers M, Verhoeven AC, Markusse HM, van de Laar MA,
Westhovens R, van Denderen JC, et al. Randomised
comparison
of
combined
step-down
prednisolone,
methotrexate and sulphasalazine with sulphasalazine alone in
early rheumatoid arthritis. Lancet 1997;350:309-18.
18. Scott DL, Smolen JS, Kalden JR, van de Putte LB, Larsen A,
Kvien TK, et al, for the European Leflunomide Study Group.
Treatment of active rheumatoid arthritis with leflunomide:
two year follow up of a double blind, placebo controlled trial
versus sulfasalazine. Ann Rheum Dis 2001;60:913–23.